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more potent predictor of total mortality than SBP or DBP.Pulse pressure and risk of total mortality and cardiovascular
For predicting cardiovascular events, SBP was superior to PPevents in patients on chronic hemodialysis.
or DBP.Background. Pulse pressure (PP) has been shown as a risk
factor for mortality or cardiovascular events in several studies.
However, the impact of PP on prognosis in a cohort of chronic
hemodialysis patients has not been sufficiently studied. We
Hypertension is a potent contributor to a poor progno-examined the effect of PP on total mortality and cardiovascular
sis [1], and a significant predictor of cardiovascular mor-events in chronic hemodialysis patients, and whether PP adds
useful value to systolic blood pressure (SBP) or diastolic blood tality [2] and stroke [3] in patients undergoing chronic
pressure (DBP) for predicting total mortality and cardiovascu- dialysis. High systolic blood pressure (SBP) has been
lar events in chronic hemodialysis patients. shown to predict a poor prognosis in hemodialysis pa-Methods. Chronic hemodialysis patients (N  1243, 720
tients [4]. In contrast, Duratini, Imperiali and Sasdellimen, 523 women) alive on January 1, 1991 at baseline were
involved in this study. Cox regression, adjusted for age, sex, found no significant difference in survival between nor-
and other risk factors, was used to assess the relation between motension and hypertension in dialysis patients [5], and
blood pressure components and risk of death and cardiovascu- a “U” curve phenomenon between SBP and cardiovascu-
lar events over a nine-year follow-up.
lar prognosis was observed by Zagar et al [6]. Moreover,Results. The association with the risk of total mortality was
Iseki et al previously reported that low diastolic bloodpositive for PP (P  0.002) and SBP (P  0.04), but not
significant for DBP (P  0.4), considering each pressure indi- pressure (DBP) was a significant risk factor of total mor-
vidually (single blood pressure component model, SPM); of tality in chronic hemodialysis patients [7]. These results
the three measurements, PP yielded the highest 2 value. When lead to the hypotheses that high SBP and low DBP maySBP and DBP were jointly entered into the Cox regression
be significant predictors of mortality or subsequent car-model (dual blood pressure component model, DPM), the asso-
ciation with the risk of total mortality was positive for SBP diovascular events in chronic hemodialysis patients.
(HR, 1.083; 95% CI, 1.030 to 1.137) and negative for DBP Blood pressure propagates through the arterial tree
(HR, 0.886; 0.808 to 0.970). After the addition of diabetes as a repetitive continuous wave and is more accurately
mellitus as an adjusted variable to the model, PP was not a
described as consisting of a pulsatile component and asignificant predictor for total mortality; PP was a significant
steady component [8]. The pulsatile component is pulsepredictor for total mortality in non-diabetic patients, but not
in diabetic patients. PP was positively associated with the risk pressure (PP), which depends on ventricular ejection,
of stroke, and stroke and AMI; however, predictive value of arterial stiffness, and timing of wave reflections. The
PP for each endpoint was not superior to SBP and DBP in
steady component is mean pressure, which is determinedSPM. In DPM with SBP and DBP, the association with the
mainly by cardiac output and vascular resistance. PP hasrisk of stroke and acute myocardial infarction (AMI) was posi-
tive for SBP (P  0.02) but not significant for DBP (P  0.5). been shown as an independent risk factor for mortality
In DPM with SBP and PP, the association with the risk of or cardiovascular events in several studies in screened
stroke and AMI was positive for SBP (P  0.01) but not populations [9–12], hypertensive subjects [13–17], thesignificant for PP (P  0.5).
elderly cohort [18] and patients with significant left ven-Conclusions. In non-diabetic patients on chronic hemodialy-
tricular dysfunction after myocardial infarction [19].sis, PP was an independent predictor of total mortality. PP was
Amar et al examined 57 chronic hemodialysis dialysis
patients and clearly demonstrated that 24-hour ambula-Key words: systolic blood pressure, diastolic blood pressure, hyperten-
sion, stroke, acute myocardial infarction. tory PPs were potent indicators of cardiovascular death
[20]. However, the impact of PP on prognosis in a rela-
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PP on total mortality and cardiovascular events in a mined by the criteria used in the study of Maillox et al
large cohort of chronic dialysis patients, and to examine [25]
whether PP adds useful value to SBP and DBP for pre-
Statistical analysisdicting total mortality and cardiovascular events in
chronic hemodialysis patients. The unpaired t test or the 2 test was used to compare
values or ratios between patients living or deceased.
Trends of event rates according to the level of PP wereMETHODS
tested by regression analysis.
Subjects The method of previous reports [12, 15] was modified
All hemodialysis patients in Okinawa, Japan, alive on and used for data analysis in the relationships between
January 1, 1991 were considered for the present study, pressures (SBP, DBP and PP) and risk of total mortality
and patients who consented were followed up until De- or cardiovascular events. The associations of hazard ra-
cember 31, 1999. The demographics of this patient popu- tios (HRs) of total mortality, stroke, AMI, and stroke 
lation were published previously [7]. Briefly, patients AMI to single (SBP, DBP, or PP) and dual (PP-SBP,
with end-stage renal disease who survived at least one PP-DBP, and SBP-DBP) blood pressure components,
month of dialysis were registered as chronic dialysis pa- as continuous variables, were evaluated by Cox pro-
tients in the Okinawa Dialysis Study (OKIDS) registry. portional hazards model [26]. Superiority of BP compo-
A total of 1243 patients (720 men, 523 women) were nent in predicting end points was decided by 2 value.
receiving maintenance hemodialysis as of January 1, Patients receiving renal transplantation or transferring
1991, when the study period began. All outcomes were outside Okinawa were included as censored cases. PP
known and confirmed. In 1041 patients (83.7%), dialysis was calculated from SBP and DBP (PP  SBP  DBP).
was performed three times per week and in 708 patients Models were adjusted for sex, age, duration of hemodial-
(57.0%) the dialysis time was 3.5 to 4.0 hours per session. ysis, smoking, serum creatinine, serum albumin, and pre-
Bicarbonate solution was used as the dialysate in all vious cardiovascular complications. StatView 5.0 soft-
patients; note that re-use of a dialyzer is not permitted in ware (SAS Institute, Cary, NC, USA) was used for data
Japan. Baseline data of laboratory and clinical variables analysis.
were obtained before the first dialysis session in January Survival curves were estimated with the Kaplan-Meier
1991. Similarly, baseline SBP and DBP values were re- method and a log-rank test was used to compare groups
corded to establish blood pressure status pre-dialysis according to PP. Multiple linear regression model was
[21].
used to determine the independent predictors of PP. A
P value 0.05 was considered to be significant.Diagnosis of events
Hazard ratios of total mortality, and stroke and AMIStroke was diagnosed by both clinical symptoms and
were plotted with DBP for each SBP group (110, 130,computed tomography (CT) brain scan [3] according to
150, 170 and 190 mm Hg). An SBP of 130 and DBP ofthe criteria of the Ad Hoc Committee of the Ministry
80 mm Hg were selected as the references values havingof Health and Welfare on Cerebrovascular Disease [22].
an HR of 1.0.CT brain scan was performed in almost all patients with
clinical disorders of stroke [23]. The time after the initial
clinical symptoms of stroke was less than 48 hours, and RESULTS
if needed the CT scan was repeated. Therefore, we regis- Characteristics of the cohort
tered only definite cases of stroke that presented both
The duration of follow-up (mean  SD) was 75.8 CT brain scan and clinical symptoms. Acute myocardial
38.3 months. During the follow-up period, 475 patientsinfarction (AMI) was diagnosed when it was confirmed
died. Overall death rate was 60.3 deaths per 1000 patient-by electrocardiogram and/or changes in serum enzymes
years. Table 1 shows the baseline variables of patientswith the criteria used in the MONICA project [24]. Car-
who died and who were alive. In the patients who died,diovascular events were defined as events of stroke and
age was greater, DBP was lower, and PP was higher thanAMI. Cardiovascular death was defined as death from
that in the living patients. Duration of hemodialysis wasstroke and AMI. Fatal stroke or fatal AMI were defined
significantly shorter, and serum albumin and serum cre-the death within 30 days after onset on the events. Previ-
atinine were also significantly lower in those who died.ous cardiovascular complication was defined as a history
All patients had a similar percentage use of antihyperten-of stroke and myocardial infarction. All patients were
sive drug therapies. The percentage of patients diag-followed up until events of stroke or AMI, death from
nosed with diabetes mellitus and previous cardiovascularall causes, renal transplantation, transfer outside of Oki-
complications (stroke or AMI) was greater in the pa-nawa, or the end of 1999. All of these events were con-
firmed from medical records. Cause of death was deter- tients who died than that in the living patients.
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Table 1. Characteristics of the patients
All Non-fatal Fatal
Characteristics N  1234 N  768 N  475 P a
Male 720 (58) 451 (59) 269 (57) 0.44
Age years 52.314.7 46.412.5 61.912.9 0.0001
Systolic blood pressure mm Hg 151.523.4 150.822.9 152.724.1 0.16
Diastolic blood pressure mm Hg 80.913.4 82.813.6 78.012.6 0.0001
Pulse pressure mm Hg 70.618.1 68.016.8 74.719.4 0.0001
Body mass index kg/m2 21.63.2 21.63.1 21.53.3 0.58
Duration of hemodialysis months 62.250.8 66.150.8 55.950.1 0.0006
Serum albumin g/dL 3.80.4 3.90.4 3.70.4 0.0001
Serum creatinine mg/dL 13.13.4 14.03.1 11.73.3 0.0001
Smoker 289 (24) 196 (26) 93 (20) 0.01
Antihypertensive treatment 646 (52) 398 (52) 248 (52) 0.94
Diabetes mellitus 212 (17) 65 (8) 147 (31) 0.0001
Previous cardiovascular complications 77 (6) 32 (4) 45 (9) 0.0003
Duration of follow-up months 75.838.2 95.528.2 44.230.2 0.0001
Values are expressed mean  SD, or number (%).
aP value is non-fatal vs. fatal patients
Fig. 1. Primary events in 1243 hemodialysis
patients. N denotes the number of patients.
Abbreviations are: RTx, renal transplanta-
tion; AMI, acute myocardial infarction.
Outcome during nine-year-follow-up period
The outcome of 1243 patients is presented in Figure
1. The incidence of all stroke  AMI was 17.6 per 1000
patient-years. Incidence of stroke was 14.4 per 1000 pa-
Table 2. Primary events and baseline pulse pressuretient-years and the incidence of AMI was 3.2 per 1000
patient-years. The number and event rate (%) of total Baseline pulse pressure mm Hg
mortality or cardiovascular events at each level of base- 59 60–79 80–99 100 Total
Event N  264 N  544 N  315 N  120 N  1243line PP are presented in Table 2. The correlation of event
rate in relation to the level of PP was significant for the Total mortality 74 (28) 184 (33) 145 (46) 72 (60) 475 (38)
Stroke  AMIcategories total mortality (P  0.01), but not significant
All 17 (6.4) 68 (12) 36 (11) 18 (25) 139 (11)in other categories. Fatal 9 (3.4) 32 (5.8) 17 (5.3) 10 (8.3) 68 (5.4)
Non-fatal 8 (3.0) 36 (6.6) 19 (6.0) 8 (6.6) 71 (5.7)
Hazard ratios in single blood pressure components Stroke
All 14 (5.3) 59 (10) 28 (8.8) 13 (10) 114 (9.1)model (SPM) or dual blood pressure component
Fatal 8 (3.0) 28 (5.1) 14 (4.4) 6 (5.0) 56 (4.5)
model (DPM) Non-fatal 6 (2.2) 31 (5.6) 14 (4.4) 7 (5.8) 58 (4.6)
AMIHazard ratios of total mortality, stroke, AMI, and
All 3 (1.1) 9 (1.6) 8 (2.5) 5 (0.8) 25 (2.0)
stroke  AMI were present in both SPM and DPM Fatal 1 (0.3) 4 (0.7) 3 (1.2) 4 (0.7) 12 (0.9)
Non-fatal 2 (0.7) 5 (0.9) 5 (1.5) 1 (0.8) 13 (1.0)(Tables 3, 4, 5, 6). Model A was adjusted for age, sex,
Values are the number (the event rate). AMI is acute myocardial infarction.duration of hemodialysis, smoking, serum creatinine, and
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Table 3. Results of Cox proportional hazards regression analysis relating incidence of total mortality to single
and dual blood pressure components of SBP, DBP, and PP
Model Aa Model Bb
Hazard ratio/10 mm Hg (CI)c P value Hazard ratio/10 mm Hg (CI)c P value
Single blood pressure
components mm Hg
PP 1.080 (1.030–1.137) 0.002 1.040 (0.990–1.104) 0.1
SBP 1.040 (1.000–1.082) 0.04 1.020 (0.980–1.061) 0.4
DBP 0.970 (0.904–1.051) 0.4 0.970 (0.895–1.040) 0.3
Dual blood pressure
components mm Hg
Model 1
PP 1.127 (1.030–1.743) 0.01 1.083 (0.990–1.195) 0.08
SBP 0.960 (0.895–1.030) 0.2 0.960 (0.895–1.010) 0.3
Model 2
PP 1.083 (1.030–1.135) 0.001 1.040 (0.990–1.104) 0.09
DBP 0.960 (0.895–1.030) 0.2 0.960 (0.895–1.040) 0.3
Model 3
SBP 1.083 (1.030–1.137) 0.001 1.040 (0.990–1.104) 0.09
DBP 0.886 (0.808–0.970) 0.01 0.923 (0.833–1.010) 0.08
Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; CI, 95% confidence interval.
a Model A was adjusted for age, sex, duration of hemodialysis, smoking, serum creatinine, serum albumin, and previous cardiovascular complications
b Model B was adjusted for variables used in Model A and diabetes mellitus
c Associated with a 10 mm Hg increment in the corresponding blood pressure component
Table 4. Results of Cox proportional hazards regression analysis relating incidence of stroke to single
and dual blood pressure components of SBP, DBP, and PP
Model Aa Model Bb
Hazard ratio/10 mm Hg (CI)c P value Hazard ratio/10 mm Hg (CI)c P value
Single blood pressure
components mm Hg
PP 1.127 (1.010–1.243) 0.02 1.105 (0.990–1.230) 0.08
SBP 1.116 (1.030–1.207) 0.007 1.105 (1.020–1.207) 0.01
DBP 1.173 (1.020–1.357) 0.02 1.173 (1.020–1.357) 0.02
Dual blood pressure
components mm Hg
Model 1
PP 0.941 (0.776–1.137) 0.4 0.923 (0.768–1.126) 0.4
SBP 1.161 (1.000–1.343) 0.04 1.015 (1.000–1.343) 0.04
Model 2
PP 1.094 (0.980–1.218) 0.10 1.072 (0.960–1.207) 0.1
DBP 1.161 (1.000–1.343) 0.04 1.161 (1.000–1.343) 0.04
Model 3
SBP 1.094 (0.980–1.218) 0.1 1.072 (0.960–1.207) 0.1
DBP 1.061 (0.877–1.280) 0.5 1.083 (0.886–1.305) 0.4
Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; CI, 95% confidence interval.
a Model A was adjusted for age, sex, duration of hemodialysis, smoking, serum creatinine, serum albumin, and previous cardiovascular complications
b Model B was adjusted for variables used in Model A and diabetes mellitus
c Associated with a 10 mm Hg increment in the corresponding blood pressure component
previous cardiovascular complications. Model B was ad- interval) were 1.083 (1.030 to 1.137) for SBP and 0.886
(0.808 to 0.970) for DBP. No incremental value of SBPjusted for variables used in model A and diabetes mel-
litus. or DBP was observed in the combination of PP and SBP
(model 1) or PP and DBP (model 2), respectively, in
Total mortality predicting total mortality. When diabetes mellitus was
added to the adjusted variables (model B), neither SBP,Of the three components (SBP, DBP, PP) in SPM,
model A, PP was the most significant predictor of total DBP, nor PP was significant predictor of total mortality
in SPM or DPM (Table 3).mortality risk (Table 3); the 2 values were 3.9 for SBP,
0.4 for DBP, and 9.2 for PP. In DPM, when SBP and
StrokeDBP were jointly entered into the model (model 3), the
association with risk of total mortality was positive for In model A, the association with stroke risk was posi-
tive for SBP, DBP, and PP, considering SPM (Table 4).SBP and negative for DBP: HR values (95% confidence
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Table 5. Results of Cox proportional hazards regression analysis relating incidence of AMI to single
and dual blood pressure components of SBP, DBP, and PP
Model Aa Model Bb
Hazard ratio/10 mm Hg (CI)c P value Hazard ratio/10 mm Hg (CI)c P value
Single blood pressure
components mm Hg
PP 1.246 (1.000–1.552) 0.05 1.150 (0.922–1.438) 0.2
SBP 1.233 (1.040–1.466) 0.01 1.185 (1.000–1.410) 0.04
DBP 1.323 (0.970–1.790) 0.07 1.323 (0.970–1.790) 0.07
Dual blood pressure
components mm Hg
Model 1
PP 0.960 (0.637–1.438) 0.84 0.878 (0.586–1.305) 0.5
SBP 1.271 (0.932–1.724) 0.12 1.296 (0.951–1.757) 0.09
Model 2
PP 1.221 (0.970–1.538) 0.09 1.138 (0.904–1.424) 0.2
DBP 1.271 (0.932–1.724) 0.1 1.296 (0.951–1.757) 0.09
Model 3
SBP 1.221 (0.970–1.538) 0.09 1.138 (0.904–1.424) 0.2
DBP 1.040 (0.693–1.567) 0.8 1.138 (0.768–1.693) 0.5
Abbreviations are: AMI, acute mycardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; CI, 95% confidence interval.
a Model A was adjusted for age, sex, duration of hemodialysis, smoking, serum creatinine, serum albumin, and previous cardiovascular complications
b Model B was adjusted for variables used in Model A and diabetes mellitus
c Associated with a 10 mm Hg increment in the corresponding blood pressure component
Table 6. Results of Cox proportional hazards regression analysis relating incidence of stroke and AMI to single
and dual blood pressure components of SBP, DBP, and PP
Model Aa Model Bb
Hazard ratio/10 mm Hg (CI)c P value Hazard ratio/10 mm Hg (CI)c P value
Single blood pressure
components mm Hg
PP 1.127 (1.030–1.243) 0.01 1.105 (1.000–1.218) 0.04
SBP 1.138 (1.061–1.230) 0.0006 1.127 (1.040–1.270) 0.002
DBP 1.197 (1.051–1.370) 0.006 1.197 (1.051–1.370) 0.007
Dual blood pressure
components mm Hg
Model 1
PP 0.951 (0.792–1.126) 0.5 0.923 (0.843–1.093) 0.3
SBP 1.173 (1.030–1.343) 0.01 1.185 (1.040–1.343) 0.01
Model 2
PP 1.116 (1.010–1.230) 0.02 1.094 (0.990–1.207) 0.09
DBP 1.173 (1.030–1.343) 0.01 1.185 (1.159–1.343) 0.01
Model 3
SBP 1.116 (1.010–1.230) 0.02 1.094 (0.990–1.207) 0.09
DBP 1.051 (0.886–1.255) 0.5 1.083 (0.913–1.292) 0.3
Abbreviations are: AMI, acute myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; CI, 95% confidence interval.
a Model A was adjusted for age, sex, duration of hemodialysis, smoking, serum creatinine, serum albumin, and previous cardiovascular complications
b Model B was adjusted for variables used in Model A and diabetes mellitus
c Associated with a 10 mm Hg increment in the corresponding blood pressure component
Of the three components, SBP was the most significant, preserved after adjustment for diabetes mellitus. PP
showed only borderline significance in SPM (model A).and PP and DBP were similar in predicting stroke. DPM
showed that SBP or DBP was superior to PP for pre- No pressure component was a significant predictor of
AMI in DPM (Table 5, models 1, 2 and 3).dicting stroke (Table 4, model 1, model 2). After an
adjustment for diabetes mellitus, the predictive values
Stroke and AMIof SBP and DBP were preserved, but that of PP was
lost. Systolic blood pressure, DBP, and PP had a positive
association with stroke risk (Table 6, model A, SPM).
AMI SBP (2  11.8) was superior to PP (2  6.4) or DBP
(2 7.5) in predicting stroke and AMI. The significanceOnly SBP had a positive association with the stroke
risk in SPM (Table 5, model A). The significance was was not lost in any of the three pressure components
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Fig. 2. Survival curves by the baseline pulse pressure (PP) in non-diabetic (A; N  1031; P  0.0001) and diabetic (B; N  212; P  0.9) patients
on chronic hemodialysis. The follow-up period was from January 1, 1991 to December 31, 1999.
after an adjustment for diabetes mellitus. In DPM, SBP Joint influence of SBP and DBP on risk of total
mortality, and stroke and AMI(mode 1) or DBP (model 2) was superior to PP in pre-
dicting stroke and AMI (Table 6). In DPM with SBP For any level of DBP, subjects with higher SBP, that
and DBP (model 3), SBP was significantly positive for is, a higher PP value, had greater mortality risk (P 
predicting stroke and AMI (P  0.02), but DBP was not 0.001, Fig. 4); alternatively, for any level of SBP, those
significant (P  0.5). The significance in SBP was lost with lower DBP had greater risk (P  0.01). For any
after adjustment for diabetes mellitus. given level of DBP, subjects with higher SBP (that is,
higher PP) also had greater risk of stroke and AMI (P
HRs of PP in diabetic patients 0.02, Fig. 5), and in contrast, for any given level of SBP,
When considered the subjects with the presence (N  those with lower DBP seemed to have a greater risk,
212) or absence of diabetes mellitus (N  1031), PP but it was not significant (P  0.5).
predicted total mortality (HR, 1.072; CI 1.010 to 1.149;
Factors correlate with PPP  0.05), and stroke and AMI (HR, 1.138; CI 1.010 to
1.280; P  0.05) in non-diabetic patients but not in dia- To analyze which characteristics of this patient cohort
betic patients, after adjusting for age, sex, duration of was associated with a wide PP, we performed multiple
hemodialysis, smoker, serum creatinine, serum albumin, linear regression analysis with PP as the dependent vari-
and previous cardiovascular complications. able (Table 7). Independent variables in the analysis are
all presented in the Table. In all patients, age, body
PP and survival curves mass index, duration of hemodialysis, serum albumin,
antihypertensive treatment, and diabetes mellitus werePatients with and without diabetes were analyzed for
significant predictors of PP. When considered with orthe relationship between PP and total mortality, or car-
without diabetes mellitus, age, duration of hemodialysis,diovascular events by the Kaplan-Meier method. Figure
serum albumin, antihypertensive treatment were signifi-2 shows the survival curves of total mortality in relation to
cant predictors of PP in non-diabetic patients; body massbaseline levels of PP. Higher baseline PP ranges were as-
index and antihypertensive treatment were significantsociated with high mortality in non-diabetic patients. How-
predictors of PP in diabetic patients.ever, no appreciable differences were observed among
the subgroups in diabetic patients. Figure 3 shows the
Relationship between SBP, DBP and PPevent-free rates for cardiovascular events (stroke and
AMI) by baseline levels of PP. Higher baseline PP ranges Figure 6 shows the relation between SBP, DBP, and
quintiles of PP (N  1234). Higher SBP and lower DBPwere associated with higher rates of cardiovascular
events in non-diabetic patients, whereas no difference generated a wider range of PP. Higher SBP contributed
more to a wide PP than did lower DBP values.was observed among the subgroups in diabetic patients.
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Fig. 3. Event free rates for stroke and acute myocardial infarction (AMI) by the baseline pulse pressure in non-diabetic (A; N  1031; P  0.01)
and diabetic (B; N  212; P  0.7) patients on chronic hemodialysis. The follow-up period was from January 1, 1991 to December 31, 1999.
Fig. 4. Joint effects of systolic blood pressure (SBP) and diastolic blood Fig. 5. Joint effects of systolic blood pressure (SBP) and diastolic blood
pressure (DBP) on the risk of total mortality. Total mortality ratios pressure (DBP) on the risk of stroke and acute myocardial infarction
were calculated from the level of DBP with the SBP groups in the dual (AMI). Stroke and AMI hazard ratios were calculated from the level
BP component model (Table 3, Model A, Model 3). Hazard ratios were of DBP within the SBP groups in the dual BP component model (Table
set to a reference value of 1.0 for SBP of 130 mm Hg and DBP of 80 6, Model A, Model 3). Hazard ratios were set to a reference value of
mm Hg. Hazard ratios were plotted for SBP values of 110, 130, 150, 1.0 for an SBP of 130 mm Hg and DBP of 80 mm Hg. Hazard ratios
and 170 mm Hg, respectively. The range of DBP in the patients for were plotted for SBP values of 110, 130, 150, 170, and 190 mm Hg,
each level of SBP was used to define the plotted range of DBP. All respectively. The range of DBP in the patients for each level of SBP
estimates were adjusted for age, sex, duration of hemodialysis, smoking, was used to define the plotted range of DBP. All estimates were adjusted
serum creatinine, serum albumin and previous cardiovascular complica- for age, sex, duration of hemodialysis, smoking, serum creatinine, serum
tions. albumin and previous cardiovascular complications.
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Table 7. Results of multiple linear regression analysis with pulse pressure as the dependent variable
All Non-DM DM
Independent variables  P  P  P
Sex (male  1, female  0) 0.67 0.53 1.14 0.31 2.8 0.36
Age years 0.17 0.0001 0.19 0.0001 0.03 0.75
Body mass index kg/m2 0.30 0.04 0.15 0.36 0.91 0.02
Duration of hemodialysis months 0.04 0.0001 0.04 0.0001 0.002 0.96
Serum albumin g/dL 3.0 0.003 3.0 0.0009 3.2 0.27
Serum creatinine mg/dL 0.22 0.20 0.22 0.16 0.13 0.79
Smoker (yes  1, no  0) 1.9 0.09 1.9 0.24 5.3 0.17
Antihypertensive treatment
(treated  1, not treated  0) 10.6 0.0001 10.1 0.0001 12.3 0.0001
DM (present  1, none  0) 9.8 0.0001 — — — —
Previous cardiovascular complications
(present  1, none  0) 0.5 0.76 0.4 0.83 1.06 0.80
R2  0.21, F  34.2, P  0.0001 for all; R2  0.15, F  20.4, P  0.0001 for non-DM; R2  0.13, F  3.4, P  0.0005 for DM. DM is diabetes mellitus. In the
multiple regression analysis, pulse pressure was assigned dependent factor, and sex, age, body mass index, duration of hemodialysis, serum albumin, serum creatinine,
smoker, antihypertensive treatment, DM, and previous cardiovascular complications were assigned independent factors.
DBP values, that is, a wider PP range, correlate with
a significant risk of death in patients on hemodialysis.
Furthermore, in the present study the power of PP for
predicting total mortality was more potent than that of
SBP or DBP alone. In SPM, the association with the
risk of stroke and AMI was positive for SBP, DBP and
PP, respectively. However, in DPM with SBP and PP,
the association with the risk of stroke and AMI was
positive for SBP, but not significant for PP. Furthermore,
in DPM with SBP and DBP model, only SBP was signifi-
cantly positive for predicting stroke and AMI. These
results indicate that PP may be dependent on SBP for
predicting stroke and AMI. Previous reports showed
that PP was superior to SBP, DBP, or mean pressure in
predicting cardiovascular events [11, 12, 15, 19]. How-
ever, the superiority of PP to SBP or DBP for predicting
the risk of cardiovascular events was not evident in the
present study. For predicting cardiovascular events, SBP
was superior to PP or DBP.
Diabetes mellitus accelerates the reduction of compli-
ance of the vessel [27], and stiffening of arteries results
in increased PP through an increase in both aortic imped-
Fig. 6. Relationship between SBP () and DBP (), and the quintile
ance and pulse wave velocity as described by Domanskiof pulse pressure (PP). *P  0.05 vs. the first quintile of PP; #P  0.05
vs. the third quintile of PP. SD is standard deviation. et al [17]. Therefore, a widening PP can be driven by
diabetes mellitus, and a correlation between presence of
diabetes mellitus and wider PP was expected. Indeed,
the mean (SD) PP in diabetic patients (82 20 mm Hg)
DISCUSSION was significantly higher than in non-diabetic patients
The major findings of this nine-year follow-up study (68  16 mm Hg, P  0.0001) in the present study.
were that in a large cohort of chronic hemodialysis pa- And a multiple linear regression analysis showed that a
tients, baseline PP independently predicted the incidence correlation between presence of diabetes mellitus and
of total mortality in non-diabetic patients. The wider the wider PP was significant (Table 5). The strong association
range of PP, the greater the increased risk of mortality. between diabetes mellitus and PP explains why the PP
Higher SBP [4] or lower DBP [7] values increased the was not the predictor for the total mortality and cardio-
risk of mortality in hemodialysis patients. The results of vascular events in diabetic patients.
the present study not only support the results of previous The high prevalence of atherosclerosis-related compli-
cations and marked abnormalities of arterial compliancereports, but also confirm that higher SBP and lower
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have been well documented in hemodialysis patients patients studied for nine years, a wider PP range was
found to be a significant independent predictor of total[28, 29]. It also is known that prolonged uremia has a
deleterious effect on stiffening of the artery wall [30]. mortality in the non-diabetic patient. PP was superior
to SBP and DBP in predicting total mortality. For pre-Such known complications help rationalize the positive
relationship between a wide PP range and mortality or dicting cardiovascular events, SBP was superior to PP
and DBP. Further evidence for PP as a risk factor of totalcardiovascular events in hemodialysis patients, as shown
in this study. However, the mechanisms of accelerated mortality should be clarified by randomized prospective
studies.atherogenesis in hemodialysis patients remain a matter
for debate [31].
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